Under construction – not a live service
Sign in
Taking people in SpainNo phase

Saffron Extract Supplementation and Sleep Quality in Middle-Aged Adults

Key facts

Where
Granada, SpainSee the site

Could this be for you?

Answer for yourself. This is not a decision: only the study team can say whether you can take part.

  • Are you between 18 and 65 years old?

Source: NCT07497698, who can take part

Where in Spain

  • Universidad de GranadaGranada, SpainContact: Lucas Jurado FasoliTaking people

Questions to ask the study team

  1. How often do I need to come in, and for how long each time?
  2. Are travel costs paid?
  3. Can I keep my own doctor?
  4. What happens if I want to stop?

Contact the study team: see the registry record → Contacts and Locations

Print a page for my doctor

Trial details

Who runs it
Universidad de Granada
Trial code
NCT07497698
Record updated
13 April 2026
Original description
This randomized, triple-blind, placebo-controlled clinical trial aims to evaluate the effects of daily saffron extract supplementation (30 mg/day) for six weeks on objective and subjective sleep quality in middle-aged adults with mild-to-moderate sleep disturbances. Secondary outcomes include heart rate variability, cognitive processing speed, emotional state, perceived health status, and biochemical stress markers.Read full original descriptionShow less

Effects of Daily Saffron Extract Supplementation on Sleep Quality in Middle-Aged Adults: A Randomized, Triple-Blind, Placebo-Controlled Clinical Trial

This randomized, triple-blind, placebo-controlled clinical trial aims to evaluate the effects of daily saffron extract supplementation (30 mg/day) for six weeks on objective and subjective sleep quality in middle-aged adults with mild-to-moderate sleep disturbances. Secondary outcomes include heart rate variability, cognitive processing speed, emotional state, perceived health status, and biochemical stress markers.

Inclusion: Age 18-65 years; Mild-to-moderate sleep disturbances; BMI between 18 and 35 kg/m²; Not receiving active pharmacological or psychological treatment for sleep disorders; Willingness to comply with study procedures.

Exclusion: Diagnosed with obstructive sleep apnea, treated with CPAP; Use of medications or supplements affecting sleep; Recreational drug use; Severe neurological, psychiatric, or cardiovascular disorders; Uncontrolled medical conditions; Night shift workers; Pregnancy or breastfeeding.

ClinicalTrials.gov NCT07497698